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Abstract
Aims/hypothesis To investigate the mechanism by which
human islet amyloid polypeptide (hIAPP) fibril formation
results in calcium influx across the plasma membrane of
pancreatic beta cells, and its association with apoptosis.
Methods Cytoplasmic intracellular calcium concentrations
([Ca2+]i) were monitored for 2 h as the 340/380 nm fluo-
rescence ratio in fura-2 loaded cells of the MIN6 mouse
pancreatic beta cell line. Cell morphology was evaluat-
ed by transmission electron microscopy, and viability by
FACS.
Results hIAPP (10 μmol/l) increased [Ca2+]i in 21% of
MIN6 cells in standard buffer, and in 8% of cells in Na+-
free buffer. Transient receptor potential (TRP) channel
inhibitors (gadolinium and ruthenium red) prevented the
[Ca2+]i rise under both conditions, whilst nifedipine was only
effective in the presence of Na+. hIAPP increased apoptosis in
both insulinoma cells and islets in primary culture, and cell
viability was partially rescued by ruthenium red (p<0.001).
By RT-PCR, we detected expression of the mechanosensitive
TRP cation channel subfamily V member 4 (Trpv4) in MIN6
cells and mouse pancreas. Small interference RNA against
Trpv4 prevented hIAPP-induced [Ca2+]i rises, decreased
hIAPP-triggered expression of the endoplasmic reticulum
(ER) stress response, and reduced hIAPP-triggered cell death
by 50% (p<0.05).
Conclusions/interpretation Alterations in [Ca2+]i play a key
role in hIAPP-induced beta cell cytotoxicity. By electron
microscopy, we detected extracellular hIAPP aggregates
adjacent to irregular invaginated regions of the plasma
membrane. We propose that TRPV4 channels may sense
physical changes in the plasma membrane induced by hIAPP
aggregation, enabling Ca2+ entry, membrane depolarisation
and activation of L-type Ca2+ channels. Decreasing the ac-
tivity of TRPV4 prevented hIAPP-induced [Ca2+]i changes,
reduced hIAPP-triggered ER stress and improved cell
viability.
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Abbreviations
[Ca2+]i intracellular calcium concentration
ER endoplasmic reticulum
FBS fetal bovine serum
hIAPP human islet amyloid polypeptide
IAPP islet amyloid polypeptide
PI propidium iodide
rIAPP rodent islet amyloid polypeptide
RR ruthenium red
siRNA small interfering RNA
ThT thioflavin T
TRP transient receptor potential
TRPV4 TRP cation channel subfamily V member 4
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Introduction
Islet amyloid polypeptide (IAPP), also known as amylin, is
the main component of islet amyloid [1, 2], which is found
within the pancreatic islets of Langerhans in patients with
type 2 diabetes mellitus [3, 4]. Because deposits of islet
amyloid colocalise with areas of cell degeneration, the
process of amyloidosis has been strongly associated with
the progressive loss of pancreatic beta cell mass that is one of
the hallmarks of type 2 diabetes mellitus [5–8]. A target
region of human IAPP (hIAPP) between positions 20 and 29
is thought to be responsible for the formation of amyloid
fibrils [9]. Rodent IAPP (rIAPP), which differs from the
human sequence at several residues within this critical region,
is not amyloidogenic [9].
The process of ordered aggregation into amyloid fibrils
is a common event in many cell-degenerative diseases,
including Alzheimer’s disease, Parkinson’s disease, prion
protein related encephalopathies and several other local and
systemic amyloidoses [10]. Although the peptides that form
amyloid deposits show no apparent primary sequence
homology, they all adopt a beta strand secondary structure
after conversion to fibrils [11], suggesting that partially
folded states serve as the precursors for nucleation [12–14].
However, the toxicity of amyloidogenic peptides appears to
lie in the oligomeric intermediates rather than the mature
fibrils [15, 16]. Thus, the conversion of a normally soluble
protein into amyloid can give rise to a gain in toxic function,
providing a common mechanism by which amyloid contrib-
utes to disease pathogenesis through cell toxicity and cell
death [17].
Amyloid peptides have been reported to induce cell
death by apoptosis [6, 18–20], which may result from the
disruption of calcium homeostasis [21]. Indeed, in the
MIN6 mouse pancreatic beta cell line, we recently showed
that hIAPP triggered calcium changes that were associated
with the induction of apoptosis via a pathway involving
activation of the endoplasmic reticulum (ER) stress re-
sponse [22]. The elevation of intracellular calcium in
neurons and astrocytes has been reported to follow the
formation and extracellular deposition of several amyloid
peptides, including hIAPP [23–27], and a range of potential
underlying mechanisms for the increased calcium perme-
ability have been proposed. In cell-free systems such as
phospholipid bilayers, hIAPP amyloid has been reported to
form cation-permeable channels as a result of its insertion
into membranes [28], but also to destabilise the membrane
structure in parallel with the measured kinetics of hIAPP
fibril growth [29] and to cause a non-specific increase in
conductance [16, 30–33]. In addition, however, activation
of cell-surface receptors coupled to calcium influx has been
reported in a neural cell line exposed to beta-amyloid pep-
tide aggregation [34]. Although diverse, these mechanisms
are compatible with the idea that the cytotoxicity of hIAPP
is initiated on the cell surface and requires close contact
between the aggregation process and the beta cell plasma
membrane [6]. In regions where this occurs, the plasma
membrane of pancreatic beta cells in amyloidogenic islets
in vivo is usually characterised by ultrastructural morpho-
logical abnormalities [2, 35–37].
The aim of the present study was to investigate the
mechanism by which hIAPP fibril formation results in
calcium influx across the plasma membrane of pancreatic
beta cells and its association with apoptosis.
Methods
Cell culture The mouse pancreatic beta cell line MIN6 [38]
was cultured in Dulbecco’s modified Eagle’s medium sup-
plemented with 10% fetal bovine serum (FBS), 2 mmol/l
L-glutamine, 5 μmol/l β-mercaptoethanol, 100 U/ml peni-
cillin and 100 μg/ml streptomycin, at 37°C with 5% CO2.
Islet isolation and culture Islets were isolated by collagenase
(Roche Diagnostics, Indianapolis, IN, USA) digestion of the
pancreas, and separated from exocrine tissue on a Histopaque
(Sigma-Aldrich, Steinheim, Germany) density gradient.
Hand-picked islets were transferred to RPMI-1640 medium
(Gibco-BRL, Paisley, UK) containing 11.1 mmol/l glucose
and supplemented with 10% FBS, 2 mmol/l L-glutamine,
100 U/ml penicillin and 100 μg/ml streptomycin, and
cultured at 37°C with 5% CO2. All procedures were carried
out with male mice on a C57BL/6 background and in
accordance with the Institutional Animal Ethics Committee’s
policies.
Solutions and chemicals Synthetic human and rat IAPP
peptides (Bachem, Bubendorf, Switzerland) were dissolved
in sterile water at 500 μmol/l and incubated at room
temperature for 10 min before use at a final concentration
of 10 μmol/l. Drugs and chemicals were purchased from
Sigma-Aldrich (Poole, UK) unless otherwise stated, and
were added to the bath solutions as indicated. The bath solution
for calcium imaging experiments was a Krebs–Ringer bicar-
bonate solution containing (mmol/l): 149.5 NaCl, 6.5 KCl,
31.2 NaHCO3, 2.7 MgCl2, 4.3 CaCl2 and 26 HEPES
(pH 7.4), to which 1.3% (wt/vol.) BSA and 1 mmol/l glucose
were added. The Na+-free buffer contained choline+ in place
of Na+.
Transmission electron microscopy For ultrastructural anal-
ysis of insoluble aggregates, a 4 μl sample of the same
suspension was applied to a Formvar carbon-coated copper
grid for 1 min, dried, stained with 2% (wt/vol.) uranyl acetate
in water for 1 min and air dried. For cellular ultrastructural
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analysis, MIN6 cells in culture were fixed in 2.5% (wt/vol.)
glutaraldehyde in 0.1 mol/l phosphate buffer (pH 7.4) at 4°C
for 1.5 h, rinsed in 0.1 mol/l phosphate buffer and post-fixed
in osmium tetroxide 1% (wt/vol.) in the same buffer for 1 h.
The samples were dehydrated in an ascending series of
acetone concentrations, embedded in Spurr resin and poly-
merised at 60°C for 48 h. Ultra-thin sections (60-90 nm)
were cut using a Reichert-Jung Ultracut E ultramicrotome
(Leica Instruments, Nussloch, Germany). They were then
placed on 200 mesh copper grids and doubled stained with
uranyl acetate (2% wt/vol.) and lead citrate. The grids were
examined using a Jeol 1010 transmission electron micro-
scope (Jeol, Tokyo, Japan) operating at an accelerating
voltage of 80 kV.
Thioflavin T (ThT) fluorescence assay The development of
hIAPP fibrils was monitored by a ThT fluorescence assay.
Each reaction was performed with 5 μmol/l ThT in assay
buffer (50 mmol/l TRIS, 100 mmol/l KCl, 1 mmol/l EDTA,
pH 8.0) containing 10 μmol/l freshly reconstituted hIAPP
or rIAPP peptide. Measurements were recorded at 37°C by
using amicroplate spectrofluorometer (SpectraMaxGeminiXS;
Molecular Devices, Sunnyvale, CA, USA). Excitation and
emission wavelengths were set at 440 and 482 nm, respectively.
Intracellular calcium concentration [Ca2+]i measurements
Cells were plated on glass-bottom dishes (Mattek, Ashland,
MA, USA) 1–3 days prior to use and loaded with 2 μmol/l
fura-2 as the acetoxymethylester (Molecular Probes, Leiden,
the Netherlands) for 30 min in bath solution containing
1 mmol/l glucose at room temperature. Measurements were
made on an inverted Fluorescence Microscope (Olympus
IX71, Southall, UK) with a ×40 oil-immersion objective.
Excitation at 340 and 380 nm was achieved using a com-
bination of a 75 W Xenon arc lamp and a monochromator
(Cairn Research, Faversham, UK) controlled by MetaFluor
software (Molecular Devices, Wokingham, UK) and emission
was recorded with an Orca ER CCD camera (Hamamatsu
Photonics UK, Welwyn Garden City, UK) using a dichroic
mirror and a 510 nm long pass filter. Minimal and maximal
signals were recorded in the presence of 5 μmol/l ionomycin
in 5 mmol/l EGTA/0 mmol/l Ca2+ and 5 mmol/l Ca2+,
respectively, at the end of the experiment.
RNA interference Small interfering RNA (siRNA) duplexes
for mouse transient receptor potential cation channel
subfamily V member 4 (Trpv4) and amylase 2 (Amy2) were
obtained from Dharmacon (Lafayette, CO, USA). A total of
170 nmol/l of each siRNA duplexes was transfected into
MIN6 cells using Lipofectamine 2000 (Invitrogen, Carls-
bad, CA, USA). Cells were processed and analysed after
48 h of transfection. Cells treated with siRNA against Amy2
(siAmy2) were used as control. Prior to siRNA experi-
ments, transfection optimisation to ensure maximum siRNA
uptake was performed with siGLO green fluorescent control
reagent (Dharmacon). Transfection efficiency expressed as
the percentage of green fluorescent-positive cells was 91±
6% (mean±SEM from four independent experiments).
RT-PCR Total RNAwas extracted using TRI reagent (Sigma-
Aldrich) following the manufacturer’s instructions. Thereafter,
cDNAwas synthesised from 1μg total RNA using SuperScript
II RNase H reverse transcriptase (Invitrogen). PCRwas carried
out with 50 ng cDNA and specific oligonucleotide primers
using Taq DNA polymerase (Promega, Madison, WI, USA).
Primers for Trpv4 were 5′-ATCAACTCGCCCTTCAGAGA-
3′ and 5′-GGTGTTCTCTCGGGTGTTGT-3′, for β-actin
(Actb) were 5′-TGAGAGGGAAATCGTGCGTG-3′ and 5′-
TGCTTGCTGATCCACATCTGC-3′, and for analysis of
mouse X-box binding factor-1 (Xbp1) mRNA splicing were
5′-GAACCAGGAGTTAAGAACACG-3′ and 5′-AGGCAA
CAGTGTCAGAGTCC-3′. PCR products were separated
by electrophoresis on a 1.5-2.5% (wt/vol.) agarose gel and
visualised by ethidium bromide staining. Unspliced and
spliced Xbp1 (sXbp1) gave products of 205 and 179 bp,
respectively. The percentage of sXbp1 to total Xbp1 was
determined by densitometry using Quantity One software
(Bio-Rad Laboratories, Hercules, CA, USA).
Real-time quantitative RT-PCR The heat shock protein
90 kDa beta member-1 (Hsp90b1) and Actb genes were
amplified using SYBR Green PCR Core Reagents (Applied




PCR was run with 1 ng cDNA using an ABI Prism 7900HT
Sequence Detection System (Applied Biosystems) following
the manufacturer’s instructions. A standard curve of each
primer set was generated from serial dilutions of cDNA. PCR
products were verified using dissociation curve analysis after
the run using SDS software (Applied Biosystems). Actb values
were used to normalise Hsp90b1 expression.
Apoptosis assay MIN6 cells were harvested and pooled
with their medium in order to evaluate also cells that had
lost their adherent properties during apoptosis. The protocol
for isolation of single islet cells was as published previously
[22]. Islets were digested in PBS containing 0.125 mg/ml
trypsin and 0.05 mg/ml EDTA at 37°C. The cell suspension
was cycled for 5 min on ice to allow islets to sediment. The
supernatant fraction containing single cells was removed
and placed in FBS. To obtain additional single islet cells,
the digestion process was repeated three times. Thereafter,
cells were stained with annexin V-FITC and propidium
iodide (PI) using an Annexin V-FITC Apoptosis Detection
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Kit (Becton Dickinson, San Jose, CA, USA). Samples were
analysed by FACS within 1 h on a FACS Calibur with Cell
Quest software (Becton Dickinson). FACS gating based on
forward and side scatter of 20,000 cells was included for
analysis. Annexin V-FITC- and PI-negative cells were con-
sidered as viable, annexin V-FITC-positive cells as early
apoptotic and those positive for both annexin V-FITC and
PI as late apoptotic or dead cells.
Statistical analysis Data are presented as means±SEM.
Comparisons between groups were performed by the
Student’s t test. Differences in frequencies between groups
were assessed by the χ2 test.
Results
As reported previously, hIAPP was observed to aggregate
spontaneously in solution over the course of 2 h [14].
Electron microscopy of freshly prepared solutions contain-
ing 10 μmol/l hIAPP showed that prefibrillar hIAPP
structures were first observed after 10 min, with maximum
formation after 30–45 min (Fig. 1a, left panel). At 2 h we
also detected fibrils of hIAPP (Fig. 1a, right panel). The
development of hIAPP fibrils was confirmed by monitoring
the fluorescence of ThT at 482 nm, the intensity of which
reflects the binding to, and hence the formation of, amyloid
fibrils. In solutions containing 10 μmol/l hIAPP, but not
10 μmol/l rIAPP, ThT fluorescence increased throughout
the 2 h incubations, indicating the progressive formation of
fibrils (Fig. 1b).
To investigate whether hIAPP increases cytosolic calci-
um concentrations in the insulinoma cell line MIN6, we
monitored the 340/380 nm fluorescence ratio in cells loaded
with the calcium indicator dye, fura-2. When MIN6 cells
were incubated in 10 μmol/l hIAPP for 2 h, we observed a
>1.4-fold elevation of the fluorescence ratio in 21% of cells
(70/328), indicative of a rise in [Ca2+]i (Fig. 2a–e). By
contrast, no calcium changes of this magnitude were
observed in 128 cells treated with rIAPP or in 87 cells
incubated without additions (Fig. 2f,g; p<0.001 vs hIAPP).
In the cells incubated with hIAPP, the latency of the
calcium rise had a bimodal distribution, with a first peak
occurring at 25–30 min and a second at 75–90 min
(Fig. 2b). The timing of the first peak coincides with the
first appearance of IAPP deposits by light microscopy. In
those cells that exhibited a rise in [Ca2+]i, the 340/380 nm
ratio increased progressively until, in many cases, the cell
was observed to detach from the glass dish, thereby
preventing calibration of the calcium signal in individual
responsive cells. The mean peak ratio before detachment in
the cells that exhibited a calcium rise was 2.0±0.4 (n=41),
similar to the maximum ratio of 1.9±0.5 (n=72) in the
remaining cells treated at the end of the experiment with
ionomycin and 5 mmol/l Ca2+. This suggests that the calcium
concentration in affected cells rose to at least 1 μmol/l.
We next investigated whether the rise in [Ca2+]i was
dependent on calcium entry through voltage-gated Ca2+
channels. Inclusion of 5 μmol/l nifedipine in the incubation
medium significantly abolished the hIAPP-triggered rise in
the fura-2 ratio (0/198 cells responded, p<0.001 compared
with hIAPP alone) (Fig. 3a), suggesting that L-type Ca2+
channels contribute to the calcium rise in MIN6 cells. As
L-type Ca2+ channels normally only open at a threshold
membrane potential of approximately −40 mV, the most
likely explanation for their recruitment by hIAPP is as a
consequence of membrane depolarisation. To investigate
the role of Na+ ions in any initial depolarisation, we repeated
the experiments in buffer containing choline+ in place of
Na+. In the absence of hIAPP, the calcium concentration in
MIN6 cells was less stable in this Na+-free buffer, and
tended to rise slightly during the 2 h incubation, with 4/187
Fig. 1 hIAPP aggregation process. a Electron microscopy images
showing spontaneous aggregation of 10 μmol/l hIAPP. Prefibrillar
hIAPP structures were first observed after 10 min, and maximum
formation was achieved after 30–45 min (left panel). hIAPP fibrils
were detected at 2 h (right panel). Scale bar, 0.2 μm. b Formation of
hIAPP fibrils was monitored over time by the fluorescence intensity of
ThT. Experiments were performed with either 10 μmol/l hIAPP
(squares), rIAPP (triangles) or control assay solution (circles; n=8)
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cells (2%) showing a fluorescence ratio change of >1.4-fold
(Fig. 3b). This may be explained by Na+/Ca2+ exchangers
operating in reverse when extracellular Na+ is removed,
resulting in persistent Ca2+ influx, as described previously in
beta cells [39]. Removal of extracellular Na+ did not, how-
ever, prevent the larger calcium responses to hIAPP, which
were observed in 8% of cells (7/85, p<0.01 compared with
Na+-free buffer alone; Fig. 3c,d). Interestingly, however, in
Na+-free buffer, nifedipine was no longer able to abolish
hIAPP-triggered calcium responses, which were still ob-
served in 8% of cells (13/154: not significantly different
from the response rate with hIAPP in Na+-free buffer alone)
(Fig. 3e). This suggests that under Na+-free conditions, hIAPP
activates a Ca2+ influx pathway distinct from the opening of
L-type Ca2+ channels.
The results raised the possibility that a non-voltage-
dependent Ca2+ channel, such as a transient receptor potential
(TRP) channel, might be implicated in responses to hIAPP,
and we speculated that a mechanosensitive member of the
TRP channel family might play a role. To test this hypothesis,
we first investigated the effect of the relatively non-specific
TRP channel inhibitor, gadolinium (Gd3+, 100 μmol/l). In
support of our hypothesis, addition of Gd3+, in the presence of
Na+-free buffer and nifedipine, abolished the calcium responses
to hIAPP (0.3% responders, 1/311 cells, p<0.001 compared
with hIAPP in Na+-free buffer without Gd3+; Fig. 3f).
We next examined our microarray database [40] for
mechanosensitive TRP channels expressed in MIN6 cells,
and the search identified the Ca2+-permeable channel Trpv4
as a possible candidate. To investigate the potential role of
TRPV4, we tested the effect of ruthenium red (RR), a
general inhibitor of TRPV channels. In both standard buffer
and Na+-free buffer, RR (10 μmol/l) abolished the effect of
hIAPP on [Ca2+]i (only 0.6% of cells responded in the
standard bath and 1% responded in Na+-free buffer, p<
0.001 compared with hIAPP in standard or Na+-free buffer
without RR, respectively; Fig. 3g,h).
By electron microscopy, we observed that hIAPP aggre-
gates interacted with the cell membrane of MIN6 cells early
after treatment (Fig. 4a). In these regions, the plasma
membrane became irregular and exhibited membrane protru-
sions, which were clearly evident after 2 h. hIAPP-induced
membrane changes were also observed in the presence of RR,
indicating that the effect of RR was not to prevent membrane
changes or fibril formation (Fig. 4a).
To study the downstream effect of hIAPP cytotoxicity, we
measured apoptosis by FACS analysis, assessing staining for
both PI and annexin-V. Cells incubated for 24 h in the
Fig. 2 Effect of human and rIAPP on [Ca2+]i in MIN6 cells. a [Ca
2+]i
was monitored for 2 h as the 340/380 nm fluorescence ratio in fura-2
loaded MIN6 cells. Treatment with 10 μmol/l hIAPP led to the
formation of insoluble aggregates (outlined) after 30–45 min and was
associated with an increase in 340/380 nm fluorescence ratio. Image
representative of 12 independent experiments from different cell
preparations. Blue, basal [Ca2+]i; green to pink, elevate [Ca
2+]i.
b Frequency histogram of the latencies of Ca2+ responses in the
21.3% of hIAPP-treated MIN6 cells that exhibited a rise in the 340/
380 nm fluorescence ratio (n=328 cells, 12 independent experiments).
Latency was measured as the time to achieve a 1.4-fold increase in
fluorescence ratio. Latencies were binned into 15 min intervals, and
are labelled with the time at the end of the respective 15 min period.
c–e Representative traces of early responsive (<60 min) (c), late
responsive (>60 min) (d) and unresponsive (e) MIN6 cells treated with
10 μmol/l hIAPP. Traces are representative of 12 independent
experiments from different cell preparations (n=328). f No apprecia-
ble increase in 340/380 nm fluorescence ratio was observed in MIN6
cells treated with 10 μmol/l rIAPP. The trace is representative of
two independent experiments from different cell preparations (n=
128). g [Ca2+]i monitored in MIN6 cells in buffer without IAPP. The
trace is representative of four independent experiments from different
cell preparations (n=87)
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presence of hIAPP exhibited only 68% viability compared
with control cells (compared with 93% viability using
rIAPP; Fig. 4b). Addition of RR in the presence of hIAPP
improved cell viability to 79% (p=0.006), representing a
45% reduction in hIAPP-induced cell death (Fig. 4b). We
next investigated whether we could confirm the key
observed effects of RR on hIAPP cytotoxicity in primary
cultures of mouse pancreatic islets (Fig. 4d). After 72 h
treatment with or without 10 μmol/l hIAPP, islets were
disaggregated in single cells before viability was analysed
by FACS. Cell viability in treated islets decreased signif-
icantly to 22% compared with 73% in the controls (p<
0.001; Fig. 4c). Treatment with RR in the presence of
hIAPP improved islet cell viability to 45% (p<0.05),
representing a 52% reduction in hIAPP-induced apoptosis
(Fig. 4c).
We further evaluated the potential involvement of TRPV4
in hIAPP-triggered calcium changes and apoptosis using
siRNA technology. By RT-PCR, we detected Trpv4 expres-
sion in MIN6 cells, as well as liver, testis and pancreas
(Fig. 5a). Transient transfection of MIN6 cells with siRNA
against Trpv4 (siTrpv4) decreased expression of Trpv4, as
assessed by RT-PCR, whereas the control siRNA against
Amy2 (siAmy2) had no effect on Trpv4 expression (Fig. 5b).
When fura-2-loaded, siAmy2-treated MIN6 cells were
incubated in hIAPP for 2 h, elevation of the 340/380 nm
fluorescence ratio was detected in 10% of cells (14/156),
whereas siTrpv4-treated cells showed a significant protec-
tion against hIAPP-induced [Ca2+]i elevation (1% res-
ponders, 2/229 cells, p<0.001 compared with siAmy2;
Fig. 5c,d).
We also investigated whether silencing the Trpv4 gene had a
protective effect on hIAPP-induced apoptosis, by measuring
cell viability and apoptosis after 24 h of hIAPP treatment.
Cell viability was ~78% in control cells transfected with
either siAmy2 or siTrpv4. Whilst hIAPP reduced viability in
the control siAmy2 cells to 26%, it only decreased viability to
52% in the siTrpv4 cells (p=0.002 for comparison between
siAmy2 and siTrpv4 cells each treated with hIAPP). This
represents a 50% reduction in hIAPP-triggered cell death in
the cells with reduced expression of Trpv4 (Fig. 5e).
Recent findings revealed that the hIAPP-triggered calci-
um elevation and apoptosis in MIN6 cells were associated
with activation of the ER stress response [22]. To attempt to
distinguish between the possibilities that hIAPP-induced
ER stress might be either a trigger for, or a consequence of,
the observed [Ca2+]i changes, we assessed the degree of ER
stress in siTrpv4-treated cells, as these exhibited signifi-
cantly reduced hIAPP-triggered [Ca2+]i changes. ER stress
was quantified by measuring the activation of Xbp1. The
Fig. 3 Effect of Na+, nifedipine, Gd3+ and RR on [Ca2+]i changes
induced by 10 μmol/l hIAPP in MIN6 cells. a No appreciable increase
in [Ca2+]i was observed in MIN6 cells treated with 10 μmol/l hIAPP
and 5 μmol/l nifedipine for 2 h. The trace is representative of four
independent experiments from different cell preparations (n=198). b
In Na+-free buffer, [Ca2+]i was stable for 2 h in 97.9% (183/187) of
MIN6 cells in the absence of hIAPP. The trace is representative of four
independent experiments from different cell preparations (n=187). c,
d In Na+-free buffer, 10 μmol/l hIAPP treatment increased [Ca2+]i in
8.2% of MIN6 cells (7/85). Representative traces of a responsive (c)
and a non-responsive (d) cell are shown, taken from two independent
experiments on different cell preparations (n=85). e In Na+-free
buffer, administration of 5 μmol/l nifedipine could not prevent the
increases in [Ca2+]i triggered by 10 μmol/l hIAPP, which were still
observed in 8.4% of MIN6 cells (13/154). The trace is representative
of a responsive cell taken from two independent experiments on
different cell preparations (n=154). f In Na+-free buffer, [Ca2+]i was
stable in 99.7% of cells (310/311) when 100 μmol/l Gd3+ was added
in the presence of 10 μmol/l hIAPP and 5 μmol/l nifedipine. The trace
is representative of three independent experiments from different cell
preparations (n=311). g, h In the presence of 10 μmol/l RR and
10 μmol/l hIAPP, [Ca2+]i remained stable in 99.4% of MIN6 cells
(340/342) in standard bath solution (g), and in 98.8% of cells (169/
171) in Na+-free buffer (h). Traces are representative of four
independent experiments from different cell preparations in each
buffer
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spliced active form of Xbp1 encodes a key transcription
factor for upregulation of ER chaperones during ER stress
responses [41], and has been shown to be important for
maintenance of pancreatic beta cell ER function [42]. Splicing
of Xbp1 mRNA in MIN6 cells under control conditions was
23±2% of the total Xbp1 (Fig. 5f). Exposure of siAmy2-
treated cells to 10 μmol/l hIAPP for 2 h significantly
increased the levels of sXbp1 to 41±3% (p<0.05 vs basal
condition), whereas no increment was observed in cultures
treated with siTrpv4 (21±2% of total Xbp1; Fig. 5f). Twenty-
Fig. 4 Effect of 10 μmol/l RR on cell morphology and viability
induced by 10 μmol/l hIAPP in MIN6 cells. a MIN6 cells treated with
10 μmol/l hIAPP were studied over time by electron microscopy.
Images revealed that extracellular hIAPP insoluble forms were in close
contact with the plasma membrane of MIN6 cells. In these regions, the
plasma membrane became irregular, and at 24 h deep invaginations
were observed in both the absence and presence of 10 μmol/l RR. The
scale bar represents 1 μm in each image. b Apoptosis assay of MIN6
cells treated for 24 h with 10 μmol/l hIAPP and/or 10 μmol/l RR, as
indicated, measured by annexin V-FITC plus PI staining and FACS
analysis. Bars show the percentages of cells that were viable (black
bars), early apoptotic (grey bars) or late apoptotic/dead (white bars).
Results are means±SEM (n=6). ***p<0.001 compared with control;
†p<0.01 and ††p<0.001 compared with 10 μmol/l hIAPP. c Apoptosis
assays were performed on dispersed islet cells following treatments as
above, by staining with annexin V-FITC plus PI and analysis by FACS.
Bars show the percentages of cells that were viable (black bars), early
apoptotic (grey bars) or late apoptotic/dead (white bars). Results are
means±SEM (n=6). **p<0.01 and ***p<0.001 compared with
control; †p<0.05 and ††p<0.01 compared with 10 μmol/l hIAPP. d
Mouse pancreatic islets (arrowheads) were cultured for 72 h with
10 μmol/l hIAPP and/or 10 μmol/l RR, as indicated. Treatment with
10 μmol/l hIAPP led to the formation of insoluble aggregates in contact
with islet borders. Note the disintegration of the islet shape in islets
incubated with hIAPP vs controls. Representative images (×10
magnification)
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four hours after treatment, the increase of sXbp1 product had
returned to near basal levels in siAmy2-and remained normal
in siTrpv4-treated cells (30±4% and 21±0.4%, respectively;
Fig. 5f). We also studied the expression level of Hsp90b1,
which encodes a resident ER luminal molecular chaperone,
known to be elevated by the activity of sXbp1 as a
consequence of ER stress [41]. siAmy2-treated cells incu-
bated in the presence of hIAPP showed significantly
increased expression of Hsp90b1 after both 2 and 24 h (p=
0.02 and p=0.01 at 2 and 24 h, compared with untreated
siAmy2 cells). In cells treated with siTrpv4 and incubated
with hIAPP, expression of Hsp90b1 was normal at 2 and
24 h (Fig. 5g). These data represent a significant reduction
in hIAPP-triggered ER stress in the cells with reduced
expression of Trpv4 (Fig. 5f,g), which is in agreement with
the observed protection against hIAPP-triggered cell death
(Fig. 5e).
Discussion
Our results show that hIAPP triggers calcium changes in a
model of the pancreatic beta cell, the MIN6 cell line. Calcium
elevation was progressive and severe, and frequently resulted
in cell detachment. The calcium changes corresponded in time
with the appearance of hIAPP aggregates in the solution,
alterations in the surface membrane morphology, and a
reduction in cell viability. Pharmacological and siRNA experi-
ments suggested that activation of both TRPV4 and L-type
calcium channels contributed to the hIAPP-triggered calcium
rise.
The synthetic IAPP peptide concentration used in the
present study is within the range of concentrations used in
the literature to spontaneously form IAPP oligomers and
fibrils in culture [6, 9, 16, 22]. In type 2 diabetes mellitus,
IAPP fibrils are often found accumulated between beta cells
Fig. 5 Expression of Trpv4 and protective effects of siTrpv4 in the
presence of 10 μmol/l hIAPP. a Representative electrophoresis gel
images showing PCR amplification products corresponding to Trpv4
and Actb expression in MIN6 cells and mouse liver, testis and
pancreas. b siRNA duplexes for mouse Trpv4 were transfected into
MIN6 cells at 170 nmol/l. After 48 h, cells were treated with or
without 10 μmol/l hIAPP for a further 24 h. Cells treated with siAmy2
were used as a negative control. Representative electrophoresis gel
images showing PCR amplification products corresponding to Trpv4
and Actb expression in MIN6 cells following siRNA treatments. c, d
In the presence of 10 μmol/l hIAPP for 2 h, [Ca2+]i remained stable in
99% (229/231) of siTrpv4-transfected MIN6 cells (c), but increased in
10% (14/156) of siAmy2-transfected MIN6 cells (d). Traces are
representative of five independent experiments from different cell
preparations in each condition. e Apoptosis assay performed on MIN6
cells transfected with siAmy2 or siTrpv4, and treated for 24 h with or
without 10 μmol/l hIAPP compared with control (non-transfected,
untreated cells). Cells were stained with annexin V-FITC plus PI and
analysed by FACS. Bars show the percentages of cells that were viable
(black bars), early apoptotic (grey bars) or late apoptotic/dead (white
bars). Results are means±SEM (n=6). **p<0.01 and ***p<0.001
compared with siAmy2; †p<0.05 and ††p<0.01 compared with
siAmy2 with 10 μmol/l hIAPP. f RT-PCR analysis of Xbp1 splicing
was performed on MIN6 cells transfected with siAmy2 or siTrpv4,
and treated with or without 10 μmol/l hIAPP for 2 and 24 h using
primers flanking the intron excised from mouse Xbp1 mRNA. The
percentages of sXbp1 to total Xbp1 determined by densitometry are
illustrated. siAmy2 control (white bars), siAmy2 plus hIAPP (grey
bars), siTrpv4 control (black bars), siTrpv4 plus hIAPP (diagonal
stripes). Data are means±SEM (n=6); *p<0.05 compared with
siAmy2; †p<0.05 compared with siAmy2 with 10 μmol/l hIAPP.
g Induction of Hsp90b1 expression, a marker of ER stress, measured
by real-time quantitative RT-PCR on MIN6 cells transfected with
siAmy2 or siTrpv4, and treated with or without 10 μmol/l hIAPP for 2
and 24 h. siAmy2 control (white bars), siAmy2 plus hIAPP (grey bars),
siTrpv4 control (black bars), siTrpv4 plus hIAPP (diagonal stripes).
Results are means±SEM (n=6). *p<0.05 compared with siAmy2;
†p<0.01 compared with siAmy2 with 10 μmol/l hIAPP
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and islet capillaries [2, 35–37], indicating that there may be
insufficient clearance of secreted IAPP, and making it
technically difficult to estimate in vivo the IAPP concen-
trations that accumulate locally throughout the years of
disease progression. Nevertheless, we showed here that the
ultrastructural morphology of MIN6 cells in the amyloido-
genic conditions was characterised by plasma membrane
alterations compared with the control cells. These alter-
ations included cell membrane irregularities and invagina-
tions filled with fibrils, similar to those described in human
islets from type 2 diabetes mellitus patients [2, 35–37].
Amyloid oligomers (including hIAPP) have been
reported to increase [Ca2+]i in neurons and astrocytes [23–
27], although the effect of hIAPP on pancreatic beta cells is
not well documented. We showed recently that increases
in [Ca2+]i could be detected in hIAPP-treated MIN6 cells,
with associated activation of the ER stress response and
induction of apoptosis [22]. An earlier study, by contrast,
suggested that hIAPP does not trigger changes in [Ca2+]i in
insulinoma cells [43], but the conclusions were derived
from measurements of [Ca2+]i in cell populations, which
might have excluded any non-attached cells. Our finding
that individual MIN6 cells detached soon after experiencing
an hIAPP-triggered Ca2+ rise might explain the previous
failure to detect Ca2+ changes in insulinoma cells.
The mechanisms previously implicated in calcium re-
sponses to amyloid oligomers in other cell types and cell-
free systems include direct formation of Ca2+-permeable
pores by the amyloid oligomers themselves and the activation
of voltage-gated calcium channels [28, 34]. Amyloid pores
are unlikely to underlie our findings in MIN6 cells, as the
Ca2+ changes were inhibited by nifedipine, Gd3+ and RR,
none of which has been found to block amyloid channels.
The inhibition of hIAPP-triggered Ca2+ responses by
nifedipine in MIN6 cells indicated, however, that L-type
Ca2+ channels were activated by hIAPP, either as a result
of changes in the properties of the L-type Ca2+ channels
themselves, or as a secondary consequence of membrane
depolarisation. The latter idea is supported by the findings in
Na+-free buffer, as an additional nifedipine-insensitive Ca2+-
elevating pathway was identified under these conditions.
This was found to be blocked by Gd3+ or RR, indicating the
likely involvement of specific members of the TRP channel
family. siRNA mediated knockdown of the mechanosen-
sitive TRP channel, TRPV4, protected against the toxic
effects of hIAPP on [Ca2+]i as well as on induction of ER
stress and apoptosis. Our subsequent Trpv4 knockdown
experiments, using loss of cell viability as a marker of
hIAPP-induced apoptosis, supported the notion that activa-
tion of this channel may be an early response to hIAPP.
TRPV4 is a mechano- and osmosensitive channel located
on the cell surface, with a Ca2+/Na+ permeability ratio of ~6
[44], which is inhibited by Gd3+ and RR, and is not blocked
by 2-aminoethyl diphenylborinate (2-APB). The observed
morphological deformations in the plasma membrane fol-
lowing hIAPP treatment suggest that the deposition of
hIAPP insoluble aggregates, which can reach high molecular
masses [45], might weaken the mechanical strength of the
plasma membrane, making it susceptible to TRPV4 activa-
tion. We propose that it may provide a link between hIAPP-
induced mechanical perturbations of the beta cell plasma
membrane by hIAPP and the depolarising Ca2+ influx. The
finding that siTrpv4 protected against both hIAPP-induced
ER stress and [Ca2+]i changes suggests that this channel is
involved at a step that precedes the ER stress response,
perhaps at the level of [Ca2+]i modulation. However, as RR
did not protect completely against amyloid cytotoxicity, our
data cannot exclude the additional involvement of other early
mechanisms in the induction of islet amyloid cytotoxicity.
Activation of TRPV4 may play a more widespread role in
mediating some of the effects of amyloid on [Ca2+]i that
have been previously described in the literature. Amyloid-
induced Ca2+ entry has, for example, been attributed to
activation of channels with a relatively high selectivity
for Ca2+ over Na+ [46], which are insensitive to L-type Ca2+
channel blockers [26]. The potential involvement of TRPV4
and alternative mechanosensitive channels in mediating
amyloid-induced Ca2+ changes, ER stress and apoptosis in
other cell types will require further evaluation.
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